Inhibitors of cell cycle checkpoint target Wee1 kinase - a patent review (2003-2022)
{{output}}
Introduction: DNA damage repair in most malignancies with mutation of p53 is more dependent on the G2/M checkpoint. Wee1 kinase is a key regulator of the G2/M checkpoint. If Wee1 is inhibited, it results in cells with unrepaired ... ...
